Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer

The lack of an effective medical treatment for adrenocortical carcinoma (ACC) has prompted the search for better treatment protocols for ACC neoplasms. Sorafenib, a tyrosine kinase inhibitor has exhibited effectiveness in the treatment of different human tumors. Therefore, the aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerquetti, Lidia, Bucci, Barbara, Raffa, Salvatore, Amendola, Donatella, Maggio, Roberta, Lardo, Pina, Petrangeli, Elisa, Torrisi, Maria Rosaria, Toscano, Vincenzo, Pugliese, Giuseppe, Stigliano, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183165/
https://www.ncbi.nlm.nih.gov/pubmed/34108938
http://dx.doi.org/10.3389/fendo.2021.667798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183165/
https://www.ncbi.nlm.nih.gov/pubmed/34108938
http://dx.doi.org/10.3389/fendo.2021.667798

Ejemplares similares